Study
Potentially Risky Medications Reduced in Older Adults Over Time
From 2013 to 2021, the use of certain high-risk medications among seniors decreased, particularly those without clinical reasons.
Summary
In plain language
Recent research has shown a positive trend in reducing the use of potentially inappropriate medications that affect the brain and nervous system among older adults. These medications, such as certain types of sleeping pills and anti-anxiety drugs, can increase the risk of confusion, falls, and hospital visits. The study, which looked at data from 2013 to 2021, found a decrease in prescriptions for these medications, especially when there was no clear medical need. This is good news as it suggests better care practices and awareness of medication risks among healthcare providers. Seniors should discuss their medications with their doctors to ensure their prescriptions are appropriate and necessary.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study analyzed prescription patterns for potentially inappropriate medications affecting the central nervous system in seniors over several years.
The researchers used data from a large health study linked with Medicare claims to track medication usage from 2013 to 2021.
They found that the percentage of seniors receiving these high-risk medications dropped from 19.9% in 2013 to 16.2% in 2021, with the most significant decrease in medications prescribed without clear medical reasons.
However, the study didn't include data from Medicare Advantage plans, so some details may be missing.
Seniors should talk to their healthcare providers about the necessity and safety of their medications, especially if they have concerns about side effects or risks.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Potentially Risky Medications Reduced in Older Adults Over Time
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 23, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study is a retrospective analysis using large datasets, which limits its design score. Bias control is minimal due to lack of randomization. Statistical methods are standard but lack power analysis. Transparency is partial, with adherence to STROBE but no pre-registration. Conflicts of interest are not fully transparent, with some industry ties. The study is relevant to seniors and published in a high-quality journal, but lacks replication evidence.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 3.3/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 5.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study examines prescribing patterns of potentially inappropriate CNS-active medications in older adults from 2013 to 2021, finding a decline in such prescriptions, especially those without clinical indications.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Dementia
Dementia is a broad term used to describe a decline in cognitive function that interferes with daily life. It predominantly affects older adults, with symptoms like memory loss and changes in behavior. Dementia is not a normal part of aging, and early diagnosis is crucial for management.
Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It primarily impacts older adults, with symptoms gradually worsening over time. As the most common cause of dementia, Alzheimer's can lead to a significant decline in daily functioning and independence.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.